Europe's Critical Medicines Act improves supply of essential medicines

The European Commission has introduced the Critical Medicines Act to improve the supply and availability of essential medicines in the EU. Key features include a "Buy European" principle that prioritizes local production and enhanced joint procurement mechanisms. The proposal aims to reduce reliance on non-EU countries by promoting European production and establishing strategic partnerships. However, it lacks sufficient funding, with an indicative budget of €83 million for 2026-2027, which may not support large-scale production changes. Notably, the proposal does not include a coordinated EU framework for stockpiling medicines, which could lead to inefficiencies. MEPs are expected to propose amendments for better stockpiling coordination as the legislation progresses.